MSB 3.06% $1.01 mesoblast limited

MSB Trading 2020 - a new dawn, page-11378

  1. 2,821 Posts.
    lightbulb Created with Sketch. 1940
    EAP results in April were in line with other stem cell trials around the world. It works

    Phase 3 trial in record time , paid by NIH , tick

    30 % readout , DSMB says continue
    SI says “ flew through “.

    Reg says that means zero deaths

    45% readout, DSMB says continue
    Trial adjusted - No excessive BMI patients

    Reg says - unexpected deaths

    60% readout imminent
    SI says meet our new Swedish mate Nov
    FDA says fast track approved

    Reg says - That’s political arse covering, marketing and strategic partnerships in place.

    Reg

    The bottom line is that the drug did work. My guess is overwhelming efficacy with 15% death against 65% death rate. A whopping 50% improvement over current approved standard of care.


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.01
Change
0.030(3.06%)
Mkt cap ! $1.153B
Open High Low Value Volume
$1.01 $1.04 99.0¢ $5.111M 5.050M

Buyers (Bids)

No. Vol. Price($)
2 211966 $1.01
 

Sellers (Offers)

Price($) Vol. No.
$1.02 136540 9
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.